CS182792B2 - Method of production of 2,6-diaminodihydropyridines - Google Patents

Method of production of 2,6-diaminodihydropyridines

Info

Publication number
CS182792B2
CS182792B2 CS7500003602A CS360275A CS182792B2 CS 182792 B2 CS182792 B2 CS 182792B2 CS 7500003602 A CS7500003602 A CS 7500003602A CS 360275 A CS360275 A CS 360275A CS 182792 B2 CS182792 B2 CS 182792B2
Authority
CS
Czechoslovakia
Prior art keywords
diaminodihydropyridines
production
Prior art date
Application number
CS7500003602A
Other languages
Czech (cs)
English (en)
Inventor
Horst Meyer
Friedrich Bossert
Kurt Stoepel
Wulf Vater
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CS182792B2 publication Critical patent/CS182792B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
CS7500003602A 1972-03-06 1973-03-06 Method of production of 2,6-diaminodihydropyridines CS182792B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210687A DE2210687C3 (de) 1972-03-06 1972-03-06 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CS182792B2 true CS182792B2 (en) 1978-05-31

Family

ID=5838037

Family Applications (2)

Application Number Title Priority Date Filing Date
CS7500003602A CS182792B2 (en) 1972-03-06 1973-03-06 Method of production of 2,6-diaminodihydropyridines
CS7300001593A CS182781B2 (en) 1972-03-06 1973-03-06 Method of producing 2,6-diaminodihydropyridines

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS7300001593A CS182781B2 (en) 1972-03-06 1973-03-06 Method of producing 2,6-diaminodihydropyridines

Country Status (24)

Country Link
JP (2) JPS5626659B2 (nl)
KR (1) KR780000119B1 (nl)
AT (3) ATA925774A (nl)
BE (1) BE796279A (nl)
BG (2) BG20583A3 (nl)
CA (1) CA988524A (nl)
CH (2) CH580589A5 (nl)
CS (2) CS182792B2 (nl)
DD (1) DD106833A5 (nl)
DE (1) DE2210687C3 (nl)
DK (1) DK136061C (nl)
ES (1) ES412323A1 (nl)
FI (1) FI55996C (nl)
FR (1) FR2181789B1 (nl)
GB (1) GB1379005A (nl)
HU (1) HU167089B (nl)
IE (1) IE37370B1 (nl)
IL (1) IL41664A (nl)
LU (1) LU67147A1 (nl)
NL (1) NL7303137A (nl)
PL (2) PL92078B1 (nl)
RO (2) RO63068A (nl)
SE (1) SE384208B (nl)
ZA (1) ZA731501B (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen
JPS5922594U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 耳栓型ヘツドホ−ン
JPS5922593U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 ヘツドホ−ン用ホ−ン部取付構造
JPS6282898A (ja) * 1985-10-08 1987-04-16 Matsushita Electric Ind Co Ltd ヘツドホン
JPS6293060U (nl) * 1985-11-28 1987-06-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3855231A (en) * 1972-03-06 1974-12-17 Bayer Ag 2,6-diamino-1,4-dihydropyridine derivatives
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen

Also Published As

Publication number Publication date
CH577473A5 (nl) 1976-07-15
AT327904B (de) 1976-02-25
CA988524A (en) 1976-05-04
IL41664A0 (en) 1973-05-31
ZA731501B (en) 1973-11-28
BG22815A3 (nl) 1977-04-20
DE2210687C3 (de) 1981-09-24
IE37370B1 (en) 1977-07-06
FR2181789A1 (nl) 1973-12-07
RO61192A (nl) 1976-09-15
LU67147A1 (nl) 1973-05-22
FI55996C (fi) 1979-11-12
DK136061C (da) 1978-01-02
JPS5911584B2 (ja) 1984-03-16
CH580589A5 (nl) 1976-10-15
SE384208B (sv) 1976-04-26
PL92078B1 (nl) 1977-03-31
DK136061B (da) 1977-08-08
IE37370L (en) 1973-09-06
GB1379005A (en) 1975-01-02
ES412323A1 (es) 1976-01-01
JPS5699460A (en) 1981-08-10
DE2210687A1 (de) 1973-09-20
KR780000119B1 (en) 1978-04-15
HU167089B (nl) 1975-08-28
FR2181789B1 (nl) 1976-12-03
ATA925774A (de) 1975-05-15
FI55996B (fi) 1979-07-31
DE2210687B2 (de) 1980-09-04
JPS5626659B2 (nl) 1981-06-19
BG20583A3 (nl) 1975-12-05
BE796279A (fr) 1973-09-05
DD106833A5 (nl) 1974-07-05
AT324338B (de) 1975-08-25
NL7303137A (nl) 1973-09-10
IL41664A (en) 1976-01-30
JPS48103579A (nl) 1973-12-25
CS182781B2 (en) 1978-05-31
RO63068A (nl) 1978-05-15
PL89256B1 (nl) 1976-11-30

Similar Documents

Publication Publication Date Title
CS179404B2 (en) Method for production of 1,1,2,3,-tetrachlorpropene
CS171705B2 (en) Method of new antibiotic 3,'4'-dideoxycanamicine b production
CS182793B2 (en) Method for production of substituted ce-pentanorprostaglandins
CS183675B2 (en) Method of producing new benzo-1,2,4-triazin-di-n-oxides/1,4/
CS183686B2 (en) Method of producing 1-hydroxy-2-pyridones
CS182260B2 (en) Method of producing 1,3-oxidated 8alfa-estratrienes
CS183721B2 (en) Method of production of alfa-aminoacylcephalosporines
CA1023766A (en) Process for the production of 3-halogen- and 3,5-dihalogen-phenols
CS171232B2 (en) Method of 2,2-diaryl-4-(4'-aryl-4'-hydroxypiperidino) butyramides production
GB1402501A (en) Process for the production of 4-nitroso-diphenylamine
CS182234B2 (en) Method of producing n-benzhydryl-n-p-hydroxy-benzylpiperazine
CS182792B2 (en) Method of production of 2,6-diaminodihydropyridines
IL41815A (en) Process for the production of 2,5-dichloro-3-nitro-benzoic acid
CS191212B2 (en) Method of producing lysergamides
CS192504B2 (en) Method of producing cyano-methyl-thioacetyl-cephalosporins
CS193475B2 (en) Method of producing derivatives of 2beta,16 beta-bispiperazino-andrestane
CS181731B2 (en) Method of producing new derivatives of 2,10-dichlor-12h-dibenzo/d,g//1,3/dioxocine
JPS5217466A (en) Production of 55 benzoylindolinee22one
ZA738274B (en) Process for the manufacture of 9,10-seco-oestrane derivatives
CS193477B2 (en) Method of producing 15 alpha,16 alpha-methylene-4-pregnenes
CS179035B1 (en) Method for production of 2',3'-didesoxy-3'-fluorpyrimidine-nucleosides
GB1407529A (en) 1,2-dihydroindene-2-spiro-2-piperazine derivatives and process for production thereof
ZA734672B (en) Method for the production of polychromatically active thiazine-eosinates
CS179414B2 (en) Process for production of anthraquinone.
ZA737199B (en) Process for the production of 2-nitro-benzofurans